Cargando…
Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation
GATA2 deficiency syndrome is caused by autosomal dominant, heterozygous germline mutations with widespread effects on immune, pulmonary and vascular systems. Patients commonly develop hematological abnormalities including bone marrow failure, myelodysplastic syndrome (MDS) and acute myeloid leukemia...
Autores principales: | McReynolds, Lisa J., Zhang, Yubo, Yang, Yanqin, Tang, Jingrong, Mulé, Matthew, Hsu, Amy P., Townsley, Danielle M., West, Robert R., Zhu, Jun, Hickstein, Dennis D., Holland, Steven M., Calvo, Katherine R., Hourigan, Christopher S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582196/ https://www.ncbi.nlm.nih.gov/pubmed/31245276 http://dx.doi.org/10.1016/j.lrr.2019.100176 |
Ejemplares similares
-
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2017) -
A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins
por: West, Robert R., et al.
Publicado: (2023) -
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
por: Mir, Muhammad A, et al.
Publicado: (2015) -
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
por: Kinsler, Veronica A, et al.
Publicado: (2013) -
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
por: Al Seraihi, Ahad F., et al.
Publicado: (2018)